KIT AND METHOD INTENDED FOR PROSTATE SURGERY

Abstract

The present invention describes a method for performing a prostate surgical treatment, said method comprising: arranging a catheter 1 inside of a urethra of a patient and anchored against the bladder neck of the patient subsequent to the filling of the balloon stopper unit 5 with a fluid when the balloon stopper unit 5 is arranged inside of the bladder of a patient;
said method also comprising injecting at least one anesthetic agent and adrenaline or injecting botulinum toxin (Botox) and/or penicillin to the prostate via the injection tube 9 and the hollow tip 10 at an intended position of the prostate.

Moreover, the present invention also refers to a kit comprising a catheter 1 according to the present invention and one or more syringe(s) 1000 containing adrenaline and at least one anesthetic agent and/or at least a syringe 1000 or vial containing botulinum toxin (Botox) and/or penicillin.

Claims

1. A kit comprising a catheter comprising an introduction unit with a top, said introduction unit also comprising a drainage lumen hole for drainage of a urinary bladder; a balloon stopper unit in connection with and thus possible to fill via a balloon inflation connection and balloon filling tube arranged inside of the introduction unit, wherein filling of the balloon stopper unit with a fluid is intended when the balloon stopper unit is arranged inside of the bladder of a patient to provide for a stopper function of the balloon stopper unit against the bladder neck of the patient; said catheter also comprising an injection connection connected to an injection tube (9) arranged inside of the introduction unit, which injection tube extends in a hollow tip arranged to be provided to extend from the introduction unit; a drainage outlet; said kit also comprising at least one or more syringe(s) connectable to the injection connection of the catheter and containing adrenaline and at least one anesthetic agent, and/or at least a syringe or vial containing botulinum toxin (Botox) and/or penicillin.

2. The kit according to claim 1, wherein a multi-connection unit is arranged at an end of the catheter, said end being opposite to the top of the introduction unit, said multi-connection unit being arranged to hold the balloon inflation connection, the injection connection and at least a first portion of the drainage outlet.

3. The kit according to claim 1, wherein one or more of the balloon inflation connection, the injection connection and the drainage outlet are arranged with one or more valve(s).

4. The kit according to claim 1, wherein the hollow tip arranged to be provided to extend from the introduction unit has a length in the range of 30-60 mm, preferably 40-50 mm, extending from the introduction unit.

5. The kit according to claim 1, wherein the hollow tip arranged to be provided to extend from the introduction unit is arranged to extend from the introduction unit with an angle in the range of 20-40° from the introduction unit.

6. The kit according to claim 1, wherein the injection tube and hollow tip are made of PEEK (polyether ether ketone).

7. The kit according to claim 1, wherein the injection tube has a stopper so that the injection tube cannot be pulled out from the introduction unit entirely, preferably wherein the injection tube has a stopper and wherein there is a distance marking provided outside of the injection tube.

8. The kit according to claim 1, wherein the introduction unit is made of a rubber or plastic material, preferably wherein the introduction unit is provided with a marking in its lower portion.

9. The kit according to claim 1, wherein the kit also comprises a lubricant.

10. A method for performing a prostate surgical treatment, said method comprising: arranging a catheter comprising an introduction unit with a top, said introduction unit also comprising a drainage lumen hole for drainage of a urinary bladder; a balloon stopper unit in connection with and thus possible to fill via a balloon inflation connection and balloon filling tube arranged inside of the introduction unit, wherein filling of the balloon stopper unit with a fluid is intended when the balloon stopper unit is arranged inside of the bladder of a patient to provide for a stopper function of the balloon stopper unit against the bladder neck of the patient; said catheter also comprising an injection connection connected to an injection tube arranged inside of the introduction unit, which injection tube extends in a hollow tip arranged to be provided to extend from the introduction unit; a drainage outlet; inside of a urethra of a patient and anchored against the bladder neck of the patient subsequent to the filling of the balloon stopper unit with a fluid when the balloon stopper unit is arranged inside of the bladder of a patient; said method also comprising injecting at least one anesthetic agent and adrenaline or injecting botulinum toxin (Botox) and/or penicillin to the prostate via the injection tube and the hollow tip at an intended position of the prostate.

11. The method according to claim 10, wherein the method involves injecting at least one anesthetic agent to the prostate via the hollow tip and injecting adrenaline to the prostate via the hollow tip during at least a first phase of the method, wherein at least the injecting of adrenaline to the prostate is performed sequentially.

12. The method according to claim 10, wherein the method involves changing the position of the hollow tip in the prostate to enable for at least injection of adrenaline at different positions in the prostate, preferably for injection of at least one anesthetic agent and adrenaline at different positions in the prostate.

13. The method according to claim 10, wherein the method involves injecting both at least one anesthetic agent and adrenaline to one first half of the prostate, then removing the catheter from the patient and performing trimming of that first half of the prostate in a transurethral resection of the prostate (TURP) surgical treatment, then inserting the catheter again into the patient and injecting both at least one anesthetic agent and adrenaline to the second half of the prostate, then removing the catheter from the patient again and performing trimming of that second half of the prostate.

14. The method according to claim 10, wherein the method involves injecting both at least one anesthetic agent and adrenaline to one part of the prostate, then supplying heat to the surface of the prostate at a corresponding position to that part of the prostate, then injecting both at least one anesthetic agent and adrenaline to another part of the prostate and then supplying heat to the surface of the prostate at a corresponding position to that other part of the prostate, optionally by removing the catheter from the patient after the injecting of at least one anesthetic agent and adrenaline and inserting another catheter for enabling the supplying of heat via one or more heating elements.

15. The method according to claim 13, wherein the method involves a sequence of injecting both at least one anesthetic agent and adrenaline to a volume of the prostate and then performing trimming in a transurethral resection of the prostate (TURP) surgical treatment or a heat treatment of a corresponding surface of the prostate within a time frame of maximum 25 minutes, preferably maximum 20 minutes, more preferably maximum 15 minutes, and then performing yet another similar sequence to another volume of the prostate.

16. The method according to claim 11, wherein the method involves injecting at least adrenaline, preferably both at least one anesthetic agent and adrenaline, sequentially to different parts of the prostate, preferably to at least two different positions of the prostate, more preferably to four different squares of the prostate.

17. The method according to claim 10, wherein the method involves means for locating the hollow tip.

18. The method according to claim 17, wherein said means for locating is an external means, preferably an ultrasound device or a CT (computed tomography) device, or internal means to be injected through the hollow tip, preferably nanoparticles.

19. The method according to claim 10, wherein the method also involves injecting one or more cytostatic agents to the prostate.

20. The method according to claim 10, wherein the method involves injecting botulinum toxin (Botox) and/or penicillin to the prostate, preferably injecting botulinum toxin (Botox) and/or penicillin to a lower part of the prostate.

21. The method according to claim 20, wherein injecting botulinum toxin (Botox) and/or penicillin to the prostate is performed as a treatment of prostatitis.

Description

DESCRIPTION OF THE DRAWINGS

[0050] In FIG. 1 there is disclosed a kit according to one embodiment of the present invention. The kit comprises a catheter 1 comprising an introduction unit 2 with a top 3, said introduction unit 2 also comprising a drainage lumen hole 4 for drainage of a urinary bladder. Moreover, the catheter 1 also comprises a balloon stopper unit 5 in connection with and thus possible to fill via a balloon inflation connection 6 and balloon filling tube arranged inside of the introduction unit 2. The filling of the balloon stopper unit 5 with a fluid is intended when the balloon stopper unit 5 is arranged inside of the bladder of a patient to provide for a stopper function of the balloon stopper unit 5 against the bladder neck of the patient. The catheter 1 also comprises an injection connection 8 connected to an injection tube 9 arranged inside of the introduction unit 2, which injection tube 9 extends in a hollow tip 10 arranged to be provided to extend from the introduction unit 2 and into the prostate of a patient. The catheter 1 also comprises a drainage outlet 11. Moreover, according to this embodiment, the catheter 1 has a multi-connection unit 12 which holds the balloon inflation connection 6, the injection connection 8 and at least a first portion of the drainage outlet 11.

[0051] Furthermore, the kit also comprises at least one or more syringe(s) 1000 connectable to the injection connection 8 of the catheter 1 and containing adrenaline and at least one anesthetic agent, and/or at least a syringe 1000 or vial containing botulinum toxin (Botox) and/or penicillin.

[0052] In FIG. 2 there is disclosed a part shown of the catheter 1 according to the embodiment of a kit according to the embodiment shown in FIG. 1.